Fontana Rosanna

Si interessa di epatopatie virus-correlate (HBV-HDV), cirrosi biliari primitiva ed epatiti autoimmuni. Effettua la determinazione semi-quantitativa dell'HDV-RNA a scopo diagnostico; raccoglie ed analizza dati clinici di pazienti affetti da epatopatia. Partecipa a trial clinici e gestisce la sieroteca di pazienti in trattamento o in follow-up ambulatoriale.

Informazioni aggiuntive

  • Pubblicazioni Scientifiche:

    Totale pubblicazioni a partire dal 2011: 15


    Anno

    Alimentary pharmacology and therapeutics 2016; ():

    HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response.

    Niro GA, Smedile A, Fontana R, Olivero A, Ciancio A, Valvano MR, Pittaluga F, Coppola N, Wedemeyer H, Zachou K, Marrone A, Fasano M, Lotti G, Andreone P, Iacobellis A, Andriulli A, Rizzetto M


    2015; 6(): 8019

    International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.

    Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS, Xie G, Juran BD, Zhu D, Qian DC, Floyd JA, Morley KI, Prati D, Lleo A, Cusi D, Canadian-US PBC Consortium, Italian PBC Genetics Study Group, UK-PBC Consortium, Gershwin ME, Anderson CA, Lazarid


    2014; 60 (4): 1102A

    Long-Term HDV-RNA Suppression ? HBsAg Clearance in Chronic Hepatitis D Following Interferon Therapy

    Niro G.A., smedile A., Fontana R., Olivero A., Ciancio A., Pittalunga F., Coppola N., Wedemeyer H., Zachou K., Marrone A., Fasano M., Santantonio T., Lotti G., Andriulli A., Rizzetta M.

    2014; 34(9): 1369-77

    Variation in genes encoding for interferon ?-3 and ?-4 in the prediction of HCV-1 treatment-induced viral clearance.

    Palmieri O, Ippolito AM, Margaglione M, Valvano MR, Gioffreda D, Fasano M, D'Andrea G, Corritore G, Milella M, Andriulli N, Morisco F, Giannitrapani L, Latiano A, Fontana R, Gatti P, Tundo P, Barone M, Cozzolongo R, Santantonio T, Andriulli A


    2014; ():

    Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia.

    Iacobellis A, Cozzolongo R, Minerva N, Valvano MR, Niro GA, Fontana R, Palmieri O, Ippolito A, Andriulli A


    2013; 36(8): 600-5

    Variations of serum levels of adiponectin and resistin in chronic viral hepatitis.

    Durazzo M, Belci P, Niro G, Collo A, Grisoglio E, Ambrogio V, Spandre M, Fontana R, Gambino R, Cassader M, Bo S


    2013; 20(7): 502-9

    Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.

    Niro GA, Ippolito AM, Fontana R, Valvano MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di Mauro L, Andriulli A


    2013; 51(9): 1707-17

    Advance in molecular diagnostic tools for hepatitis B virus detection.

    Pazienza V, Niro GA, Fontana R, Vinciguerra M, Andriulli A


    2012; ():

    Estimates of HCV-1 Patients Attaining RVR Following Dual Therapy with Peg-Interferon and Ribavirin.

    Andriulli A, Iacobellis A, Valvano MR, Spirito F, Ippolito A, Bossa F, Terracciano F, Fontana R, Niro G


    2012; :

    Epidemiology and diagnosis of hepatitis D virus

    Niro GA, Fontana R, Ippolito AM, Andriulli A

    2012; 21(23): 5209-5221

    Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

    Juran BD, Hirschfield GM, Invernizzi P, Atkinson EJ, Li Y, Xie G, Kosoy R, Ransom M, Sun Y, Bianchi I, Schlicht EM, Lleo A, Coltescu C, Bernuzzi F, Podda M, Lammert C, Shigeta R, Chan LL, Balschun T, Marconi M, Cusi D, Mason AL, Myers RP, Milkiewicz P, Od


    2011; 54(4): 605A

    Long-Term Outcome Of Liver Disease In Patients With Hbv-Related Chronic Hepatitis Under Protracted Nucleos(T)Ide Analogs

    Niro GA et al.

    2011; 54(4): 1077A

    Kinetics Of Hdv-Rna And Hepatitis B Surface Antigen In Chronic Delta Hepatitis Under Pegylated Interferon And/Or Nucleoside Analogs Therapy

    Olivero et al.

    2011; 18(7): e206-11

    Unawareness of HBV infection among inpatients in a Southern Italian hospital.

    Ippolito AM, Niro GA, Fontana R, Lotti G, Gioffreda D, Valvano MR, Iacobellis A, Di Mauro L, Stroffolini T, Andriulli A


    2011; 43 Suppl 1(): S19-24

    Hepatitis delta virus infection: open issues.

    Niro GA, Gioffreda D, Fontana R


    {accordionfaq faqid=accordion3 faqclass="lightnessfaq defaulticon headerbackground headerborder contentbackground contentborder round5" active=0}

nuovo-css

webcamlive

Newsletter

Informativa Newsletter
  twitter   facebook   youtube   g plus